Vimarsana
Biggest News Aggregation in the World

Page 14 - Bedema News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bedema. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bedema Today - Breaking & Trending Today

CDC recommendations and clinical considerations for the treatment of severe Mpox - Vimarsana News

CDC recommendations and clinical considerations for the treatment of severe Mpox

In a recent article published in the United States (U.S.) Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report, a team of researchers discussed the medical countermeasures and clinical considerations for treating severe manifestations of Mpox.

A Revolution in the Treatment Landscape of AD - Vimarsana News

A Revolution in the Treatment Landscape of AD

Andrew N. Wilner, MD, and Richard J. Caselli, MD, discuss developments in the treatment of Alzheimer's disease.

Many patients experience persistent pain after having Clade IIb mpox - Vimarsana News

Many patients experience persistent pain after having Clade IIb mpox

In a rapid communication published in the journal Eurosurveillance, researchers presented the interim results of a medium-term follow-up [three weeks to twenty weeks following MPOX virus infection follow-up study comprising patients attending sexual health clinics in Belgium.

Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 - Vimarsana News

Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2

A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.

Novel Neuroprotective Agent Promising in Stroke - Vimarsana News

Novel Neuroprotective Agent Promising in Stroke

ApTOLL reduced mortality and infarct size and improved disability for stroke patients undergoing endovascular therapy, preliminary results show.